Orange, Purple, and the Drugs Between Them

Orange, Purple, and the Drugs Between Them

Virtual
Speaking Engagement
WilmerHale Intellectual Property Litigation Partner Andrew Danford will participate in the Boston Bar Association’s Orange, Purple, and the Drugs Between Them webinar on Thursday, May 9, discussing hot topics related to Hatch-Waxman and biosimilar litigation, including recent scrutiny from the FTC over what patents may be listed in the Orange Book.

Read More About the Event

Speakers

Notice

We appreciate your interest in WilmerHale. While we are pleased to have you contact us, please keep in mind that merely contacting WilmerHale does not create an attorney-client relationship. Such a relationship will not arise until the Firm agrees in writing to represent you in connection with a particular matter. Importantly, unless and until this has occurred, you should not provide us with any confidential information, and we have no duty to keep confidential any information that we may receive from you. Thank you for your understanding.